In newly diagnosed AML patients, serum EVs were enriched in myeloblastic markers important for AML diagnosis (CD33, CD34, and CD117), as well as in essential proteins, such as genes related to MHC class I and TGFβ1 [34]. The gene discussed is CD34; the disease is acute myeloid leukemia.